Diagnosticos da America
| Formerly | Laboratório Clínico Delboni Auriemo S.A. |
|---|---|
| Company type | Sociedade Anônima |
| B3: DASA3 | |
| Industry | Healthcare |
| Founded | 1961 |
| Headquarters | Barueri, Brazil |
Key people | Glauco Desidério, (Chairman) Pedro de Godoy Bueno, (CEO) |
| Products | Medical diagnosis |
| Revenue | US$ 1.0 billion (2013) |
| US$ 55.6 million (2013) | |
Number of employees | 35,000 |
| Website | www |
Diagnósticos da América S.A. (DASA) is a Brazil-based clinical diagnostics company. It also operates a food testing unit, advertising, publishing, human resources services, and research entities.
History
Founded in 1961, the company originally known as Laboratório Clínico Delboni Auriemo is headquartered in Barueri, Greater São Paulo and it is owned by the Brazilian billionaire family Bueno.
In 2021, DASA acquired the oncology service provider GEM (Assistência Médica Especializada) for approximately R$ 750 million, expanding its cancer care operations in the Brazilian states of Bahia, Sergipe, and Rio Grande do Norte.[1]
In 2024, Dasa and Amil agreed to combine their hospital operations in a 50/50 joint venture, comprising 25 hospitals and several oncology clinics.[2]
Currently, it competes in Brazil with Amil, Fleury and Rede D'Or[3] and its clinics work with numerous brands, such as Alvaro, CientíficaLab, Lavoisier, Delboni Auriemo, Alta, Leforte and Christóvão da Gama.
References
- ^ Arend Laier, Paula (1 July 2021). "Dasa compra empresa de serviços de oncologia por R$ 750 mi". CNN Brasil (in Brazilian Portuguese). Retrieved 10 March 2026.
- ^ "Brazil's Dasa, Amil to merge hospital businesses". Reuters. 14 June 2024. Retrieved 7 September 2025.
- ^ "DASA3.SA - Diagnosticos da America SA Profile". Reuters. Archived from the original on 29 October 2013.